← Browse by Condition
Medical Condition

lupus nephritis ln

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for lupus nephritis ln sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
2
Phase 2
1
Top Sponsors
China Immunotech (Beijing) Biotechnology Co., Ltd. 2 trials
Nanjing University School of Medicine 1 trial
Lupus Foundation of America 1 trial
NCT07236762 Phase 1
Recruiting

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
View Trial →
NCT07340463 Phase 2
Recruiting

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Enrollment
50 pts
Location
China
Sponsor
Nanjing University School of M...
View Trial →
NCT06927219
Recruiting

Research Accelerated by You Lupus Registry

Enrollment
10,000 pts
Location
United States
Sponsor
Lupus Foundation of America
View Trial →
NCT07104721 Phase 1
Recruiting

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
View Trial →